Michael M Devitt

5PUBLICATIONS
67CO-AUTHORS
ChemotherapyMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 02, 2026
Phase 1b trial of Bavdegalutamide (ARV-110) in combination with Abiraterone for metastatic prostate cancer.

|Sep 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP).

Irene Tsung, David C Smith, Elisabeth I Heath

|Oct 01, 2024
When You Get to the Fork in the Road, Take It: The Challenges in Managing Patients With Advanced Prostate Cancer.

Paul Viscuse, William P Skelton, Michael M Devitt

|Jun 04, 2024
Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers.

Patricia J Keller, Elizabeth J Adams, Rentian Wu

|Aug 19, 2022
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.

Sarmad Sadeghi, David Quinn, Tanya Dorff

Pageof 1

Frequent Collaborators

1 joint publications

Sarmad Sadeghi

1 joint publications

David Quinn

1 joint publications

Sumanta Pal

1 joint publications

Susan Groshen